- In
clinical trials,
reactogenicity is the
capacity of a
vaccine to
produce common, "expected"
adverse reactions,
especially excessive immunological responses...
- PMID 17458775. S2CID 21308968.
Clinical trial number NCT03392389 for "Safety,
Reactogenicity, and
Immunogenicity of mRNA-1653 in
Healthy Adults" at ClinicalTrials...
- on 8
August 2021.
Retrieved 17
January 2021. "Study of the Safety,
Reactogenicity and
Immunogenicity of "EpiVacCorona"
Vaccine for the
Prevention of COVID-19...
-
currently used
anthrax vaccines show
considerable local and
general reactogenicity (erythema, induration, soreness, fever) and
serious adverse reactions...
-
Using a single-injection
vaccine has
shown to not
cause any
adverse reactogenicity,
which the
possible immune response to vaccination, in
comparison to...
-
Diseases (NIAID) (1 June 2018), A
Phase I
Trial to
Evaluate the Safety,
Reactogenicity, and
Immunogenicity of MVA-BN
Yellow Fever Vaccine With and Without...
-
Clinical trial number NCT01160172 for "A
Study to
Evaluate the Safety,
Reactogenicity and
Immunogenicity of GSK Biologicals'
Staphylococcal Investigational...
-
Retrieved 6
January 2025.
Clinical trial number NCT03392389 for "Safety,
Reactogenicity, and
Immunogenicity of mRNA-1653 in
Healthy Adults" at ClinicalTrials...
-
number NCT04405076 for "Dose-Confirmation
Study to
Evaluate the Safety,
Reactogenicity, and
Immunogenicity of mRNA-1273 COVID-19
Vaccine in
Adults Aged 18...
- that
protect the RNA
strands and help
their absorption into the cells.
Reactogenicity, the
tendency of a
vaccine to
produce adverse reactions, is similar...
